Neuberger Berman Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
2019
Q3
$682K Sell
2019
Q2
$1.43M Buy
2019
Q1
$959K Buy